Davidson C, Stamford J A
Academic Department of Anaesthesia and Intensive Care, St Bartholomew's and the Royal London School of Medicine and Dentistry, Royal London Hospital, Whitechapel, London, UK.
Neurochem Int. 2000 Feb;36(2):91-6. doi: 10.1016/s0197-0186(99)00115-1.
This study reports the effect of chronic paroxetine (10 mg/kg p.o., 21 days) on 5-HT1B and 5-HT1D autoreceptors controlling stimulated 5-HT efflux in slices of rat dorsal raphe nucleus. Electrically evoked 5-HT (10 pulses, 200 Hz, 0.1 ms, 10 mA) was measured using fast cyclic voltammetry. 5-HT efflux was inhibited by CP 93129 (10 nM-10 microM) and by sumatriptan (1 nM-1 microM) agonists at 5-HT1B and 5-HT1D receptors, respectively. Chronic paroxetine did not, initially, appear to alter the sensitivity of the 5-HT1B autoreceptors to CP 93129. However, when constructed in the presence of WAY 100635 (10 nM) the selective and silent 5-HT1A antagonist, there was a significant (P < 0.001) rightward shift of the CP 93129 concentration-response curve in the paroxetine-treated rats but not in the controls, implying a desensitisation of the 5-HT1B autoreceptor by paroxetine. Chronic paroxetine did not affect the sumatriptan concentration-response curve, even with WAY 100635 present, implying that there was no (de)sensitisation of the 5-HT1D autoreceptor. These data suggest that chronic paroxetine treatment may desensitise 5-HT1B autoreceptors in the dorsal raphe nucleus but that this effect is unmasked only when the dominant 5-HT1A autoreceptor control is antagonised.
本研究报告了慢性给予帕罗西汀(10毫克/千克,口服,21天)对控制大鼠中缝背核切片中5-羟色胺(5-HT)释放的5-HT1B和5-HT1D自身受体的影响。使用快速循环伏安法测量电诱发的5-HT(10个脉冲,200赫兹,0.1毫秒,10毫安)。5-HT释放分别被5-HT1B和5-HT1D受体的激动剂CP 93129(10纳摩尔至10微摩尔)和舒马曲坦(1纳摩尔至1微摩尔)抑制。最初,慢性给予帕罗西汀似乎并未改变5-HT1B自身受体对CP 93129的敏感性。然而,当在选择性且无活性的5-HT1A拮抗剂WAY 100635(10纳摩尔)存在的情况下构建时,帕罗西汀治疗组大鼠中CP 93129浓度-反应曲线出现显著(P<0.001)右移,而对照组则未出现,这意味着帕罗西汀使5-HT1B自身受体脱敏。即使存在WAY 100635,慢性给予帕罗西汀也不影响舒马曲坦浓度-反应曲线,这表明5-HT1D自身受体没有脱敏。这些数据表明,慢性帕罗西汀治疗可能会使中缝背核中的5-HT1B自身受体脱敏,但只有在占主导地位的5-HT1A自身受体控制被拮抗时,这种效应才会显现出来。